RN7SL840P

Across TCGA pan-cancer cohorts, RN7SL840P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RN7SL840P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RN7SL840P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL840P is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

HNSC, STAD, and PRAD are the cancer types where RN7SL840P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL840P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	II,III,IV	+0.068	.006	8	view →
STAD	All	II,III,IV	+0.142	.026	3	view →
PRAD	All	All	+0.053	.041	2	view →
BRCA	All	III,IV	−0.041	.042	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RN7SL840P–HNSC

Open the HNSC breakdown →